The aroA and luxS Double-Gene Mutant Strain Has Potential to Be a Live Attenuated Vaccine against Salmonella Typhimurium
Open Access
Abstract
Salmonella Typhimurium (S. Typhimurium) is a zoonotic pathogen posing a threat to animal husbandry and public health. Due to the emergence of antibiotic-resistant strains, alternative prevention and control strategies are needed. Live attenuated vaccines are an ideal option that provide protection against an S. Typhimurium pandemic. To develop a safe and effective vaccine, double-gene mutations are recommended to attenuate virulence. In this study, we chose aroA and luxS genes, whose deletion significantly attenuates S. Typhimurium’s virulence and enhances immunogenicity, to construct the double-gene mutant vaccine strain SAT52ΔaroAΔluxS. The results show that the mutant strain’s growth rate, adherence and invasion of susceptible cells are comparable to a wild-type strain, but the intracellular survival, virulence and host persistence are significantly attenuated. Immunization assay showed that 106 colony-forming units (CFUs) of SAT52ΔaroAΔluxS conferred 100% protection against wild-type challenges; the bacteria persistence in liver and spleen were significantly reduced, and no obvious pathological lesions were observed. Therefore, the double-gene mutant strain SAT52ΔaroAΔluxS exhibits potential as a live attenuated vaccine candidate against S. Typhimurium infection.Keywords
Funding Information
- National Key R & D Program of China (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
- Guangxi Key Research and Development Program (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
- National Natural Science Foundation of China (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
- Natural Science Foundation of Shanghai (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
- National Basic Fund for Institutes by Shanghai Veterinary Research Institute (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
- Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (2023YFD1801302, AB23075145, 32172856, 31972654, 32302881, 22ZR1476100, 23ZR1476600, 2023JB02, CAAS-ASTIP-2021-SHVRI)
This publication has 58 references indexed in Scilit:
- Development and Evaluation of a Trivalent Riemerella anatipestifer-Inactivated VaccineClinical and Vaccine Immunology, 2013
- Engineering and Preclinical Evaluation of Attenuated Nontyphoidal Salmonella Strains Serving as Live Oral Vaccines and as Reagent StrainsInfection and Immunity, 2011
- A Salmonella enterica Serovar Typhimurium Succinate Dehydrogenase/Fumarate Reductase Double Mutant Is Avirulent and Immunogenic in BALB/c MiceInfection and Immunity, 2008
- LuxS Affects Flagellar Phase Variation Independently of Quorum Sensing inSalmonella entericaSerovar TyphimuriumJournal of Bacteriology, 2008
- Implication of Quorum Sensing inSalmonella entericaSerovar Typhimurium Virulence: theluxSGene Is Necessary for Expression of Genes in Pathogenicity Island 1Infection and Immunity, 2007
- Scarless and site-directed mutagenesis in Salmonella enteritidischromosomeBMC Biotechnology, 2007
- Characterization of Salmonella enterica Derivatives Harboring Defined aroC and Salmonella Pathogenicity Island 2 Type III Secretion System ( ssaV ) Mutations by Immunization of Healthy VolunteersInfection and Immunity, 2002
- A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suisMolecular Microbiology, 1999
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid VaccineThe Journal of Infectious Diseases, 1975